lenalidomide krka d.d. novo mesto (previously lenalidomide krka)
krka, d.d., novo mesto - lenalidomide hydrochloride monohydrate - multiple myeloma; lymphoma, follicular - imunosupresoare - multiple myelomalenalidomide krka d. novo mesto as monotherapy is indicated for the maintenance treatment of adult patients with newly diagnosed multiple myeloma who have undergone autologous stem cell transplantation. lenalidomide krka d. novo mesto as combination therapy with dexamethasone, or bortezomib and dexamethasone, or melphalan and prednisone (see section 4. 2) este indicat pentru tratamentul pacienților adulți cu mielom multiplu netratați anterior, care nu sunt eligibili pentru transplant. lenalidomide krka d. novo mesto in combination with dexamethasone is indicated for the treatment of multiple myeloma in adult patients who have received at least one prior therapy. follicular lymphomalenalidomide krka d. novo mesto in combination with rituximab (anti-cd20 antibody) is indicated for the treatment of adult patients with previously treated follicular lymphoma (grade 1 – 3a). multiple myelomalenalidomide krka d. novo mesto as monotherapy is indicated for the maintenance treatment of adult patients with newly diagnosed multiple myeloma who have undergone autologous stem cell transplantation. lenalidomide krka d. novo mesto as combination therapy with dexamethasone, or bortezomib and dexamethasone, or melphalan and prednisone (see section 4. 2) este indicat pentru tratamentul pacienților adulți cu mielom multiplu netratați anterior, care nu sunt eligibili pentru transplant. lenalidomide krka d. novo mesto in combination with dexamethasone is indicated for the treatment of multiple myeloma in adult patients who have received at least one prior therapy. follicular lymphomalenalidomide krka d. novo mesto in combination with rituximab (anti-cd20 antibody) is indicated for the treatment of adult patients with previously treated follicular lymphoma (grade 1 – 3a).
lenalidomida teva 5 mg
teva operations poland sp. z.o.o - polonia - lenalidomidum - caps. - 5mg - imunosupresoare alte imunosupresoare
ondansetron kalceks 2 mg/ml
akciju sabiedriba kalceks - letonia - ondansetronum - sol. inj./perf. - 2mg/ml - antiemetice antagonisti ai serotoninei (5ht-3)
akeega
janssen-cilag international n.v. - abiraterone acetate, niraparib tosilate monohydrate - neoplasmele prostatice, rezistent la castrare - agenți antineoplazici - treatment of adult patients with prostate cancer.
ceftriaxon pulbere pentru solutie injectabila 0,5 g
kievmedpreparat sap - ceftriaxonum - pulbere pentru solutie injectabila - 0,5 g
celestoderm-v unguent 0,1%
schering-plough central east ag - betamethasonum - unguent - 0,1%
celestoderm-v unguent 0,1%
schering-plough central east ag - betamethasonum - unguent - 0,1%
cellcept comprimate filmate 500 mg
roche registration ltd - micofenolat mofetil - comprimate filmate - 500 mg
cervugid ovule
s.c. ircon s.r.l. - o combinatie - ovule
actrapid hm 100 ui/ml soluţie injectabilă
novo nordisk a/s - insulinum umane - soluţie injectabilă - 100 ui/ml